SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is experiencing a sharp sell-off after Marvell canceled purchase orders from Celestial AI, citing a confidentiality breach by the company's management. The community is actively debating the company's future viability, with widespread frustration over a disclosure delay that left retail investors exposed to significant losses.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is trending as it breaks through long-standing resistance to reach new all-time highs, signaling renewed momentum in the AI hardware sector. The community is actively debating whether this surge represents a sustainable expansion driven by fundamental demand or a speculative blowoff top as the stock's market valuation continues to climb.

Moolec Science SA engages in the development and production of science-based food ingredients. Its products include pet food, animal feed, and dietary supplements. It operates through the following segments: Seed and Integrated Products, Crop Protection, Crop Nutrition, and Emerging Solutions. The company was founded by Gastón Paladini, Henk Hoogenkamp, and Martin Salinas in 2020 and is headquartered in George Town, Cayman Islands.

Moolec Science SA

Moolec Science is seeing heightened activity driven by investor excitement around its low-float status and a breakthrough in molecular farming technology, fueling speculation of a potential short squeeze. Community members are actively debating the stock's volatility and parabolic potential, with many monitoring for signs of massive volume spikes while others remain wary of its speculative history.

Bed Bath & Beyond, Inc. engages in the provision of an e-commerce platform. It offers furniture and home furnishing products and services. The company was founded on May 5, 1997 and is headquartered in Murray, UT.

Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc

Bed Bath & Beyond is seeing heightened activity following a reported revenue rebound that community members are debating as either a genuine operational turnaround or a continuation of speculative volatility. Discussions are centered on the CEO's new strategic direction, with investors closely watching the company's efforts to integrate acquired assets and manage costs after long-term stagnation.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble Inc. is seeing intense investor focus fueled by a record-high short interest of over 27 million shares and an acquisition of Northern Data that significantly boosts its GPU capacity and AI cloud infrastructure. The community is actively discussing the potential for a massive short squeeze, citing high borrow rates and strategic investment from Tether as key factors that could drive the stock price higher.

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Vir Biotechnology Inc

Vir Biotechnology is trending as investors digest a major oncology collaboration with Astellas and promising Phase 1 data for its prostate cancer candidate, sparking heated debate over whether the stock's significant move is a sustainable rerating or another volatile pump-and-dump. While bullish sentiment focuses on the company's strong cash position and transformative pipeline, the community is deeply divided, with many traders actively discussing the risk of potential dilution or a sharp pullback following the recent surge.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is drawing significant attention as investors speculate on potential buyout scenarios or a major turnaround strategy following persistent stock weakness and leadership uncertainty. The community is actively debating the stock's high short interest and dividend appeal, with many watching for a CEO announcement or activist intervention to drive a potential squeeze.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending as the market anticipates a high-stakes earnings report, with investor focus intensified by the company's expanding AI infrastructure, including its partnership with Anthropic and the deployment of custom Graviton chips. Community discussions are heavily centered on AWS's margin growth and the strategic implications of these AI-driven capital expenditures against a broader backdrop of mega-cap tech volatility.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package, International Package, and Supply Chain Solutions. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The Supply Chain Solutions is involved in forwarding, logistics, Coyote, Marken, and UPS Mail Innovations. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

UPS is trending as investors monitor restructuring efforts, including significant workforce reductions and the strategic exit from low-margin Amazon volume ahead of earnings. Community discussion is polarized, focusing on dividend sustainability, management's pivot toward high-margin segments, and the potential impact of labor-related legal hurdles on the company's turnaround.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending as investors weigh strong monetization growth and profitability against concerns about platform engagement and its valuation compared to high-growth peers. The community is actively debating the stock's potential for a breakout, with many discussions centered on comparing its performance and growth prospects to other high-beta tech assets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Xenon Pharmaceuticals Highlights Strong Phase III Azetukalner Data, Q3 NDA Plans at Bloom Burton Conference

Xenon Pharmaceuticals (NASDAQ:XENE) provided an update on its clinical and pipeline progress at the Bloom Burton conference, with CEO Ian Mortimer highlighting recent Phase III results for lead program azetukalner, plans for regulatory filings, and continued expansion into psychiatry and pain.

Lead...

Peregrine Capital Management LLC Invests $7.84 Million in Xenon Pharmaceuticals Inc. $XENE

Peregrine Capital Management LLC acquired a new position in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) during the fourth quarter, according to the company in its most recent...

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Average Recommendation of "Buy" by Brokerages

Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) has received a consensus recommendation of "Buy" from the nineteen analysts that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, sixteen have assigned a buy rating...

Xenon Pharmaceuticals (NASDAQ:XENE) Sees Strong Trading Volume  - What's Next?

Xenon Pharmaceuticals (NASDAQ:XENE) Sees Large Volume Increase - Should You Buy...

Aberdeen Group plc Increases Stock Position in Xenon Pharmaceuticals Inc. $XENE

Aberdeen Group plc raised its stake in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) by 29.6% in the 4th quarter, according to its most recent 13F filing with the Securities...

Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE)

Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) was the target of unusually large options trading activity on Wednesday. Traders bought 4,063 put options on the stock. This represents an...

Assenagon Asset Management S.A. Invests $5.34 Million in Xenon Pharmaceuticals Inc. $XENE

Assenagon Asset Management S.A. acquired a new stake in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) in the fourth quarter, according to the company in its most recent Form 13F...

Xenon Pharmaceuticals (NASDAQ:XENE) Stock Price Crosses Above Fifty Day Moving Average - Time to Sell?

Xenon Pharmaceuticals (NASDAQ:XENE) Share Price Crosses Above 50-Day Moving Average - Should You Sell...

Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know

Key PointsThe chief medical officer of Xenon Pharmaceuticals directly sold 1,410 common shares for a transaction value of $78,000 on March 13, 2026...

Xenon Pharmaceuticals Stock Soars 20% in 3 Months: Here's Why

XENE shares gain 20% in 3 months as positive phase III data for epilepsy drug azetukalner and pipeline progress boost outlook and investor confidence.

Xenon Pharmaceuticals, Inc. is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

Current Price	$54.26
Prev Close	$55.24
Open	$55.03
Dividend Yield	0.00%
50-Day Moving Average	$52.70
Beta	0.84
Avg. Volume	2.28M
PE Ratio	-12.44

52-Week High	$63.95
52-Week Low	$28.19
Market Capitalization	$5.27B
EPS (Annual)	-$4.36
Price to Book	7.46
Revenue Per Employee	$20,270.27

XENE
Xenon Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest XENE News

XENEXenon Pharmaceuticals Inc